Channel-mediated ATP release in the nervous system.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 04 2023
Historique:
received: 02 11 2022
revised: 10 01 2023
accepted: 19 01 2023
pubmed: 24 1 2023
medline: 3 3 2023
entrez: 23 1 2023
Statut: ppublish

Résumé

ATP is well established as a transmitter and modulator in the peripheral and central nervous system. While conventional exocytotic release of ATP at synapses occurs, this transmitter is unusual in also being released into the extracellular space via large-pored plasma membrane channels. This review considers the channels that are known to be permeable to ATP and some of the functions of channel-mediated ATP release. While the possibility of ATP release via channels mediating volume transmission has been known for some time, localised ATP release via channels at specialised synapses made by taste cells to the afferent nerve has recently been documented in taste buds. This raises the prospect that "channel synapses" may occur in other contexts. However, volume transmission and channel synapses are not necessarily mutually exclusive. We suggest that certain glial cells in the brain stem and hypothalamus, which possess long processes and are known to release ATP, may be candidates for both modes of ATP release -channel-mediated volume transmission in the region of their somata and more localised transmission possibly via either conventional or channel synapses from their processes at distal targets. Finally, we consider the different characteristics of vesicular and channel synapses and suggest that channel synapses may be advantageous in requiring less energy than their conventional vesicular counterparts. This article is part of the Special Issue on "Purinergic Signaling: 50 years".

Identifiants

pubmed: 36690324
pii: S0028-3908(23)00025-4
doi: 10.1016/j.neuropharm.2023.109435
pii:
doi:

Substances chimiques

Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109435

Subventions

Organisme : Medical Research Council
ID : MR/N003918/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J003786/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601748
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001259
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M022692/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P010393/1
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Nicholas Dale (N)

School of Life Sciences, University of Warwick, Coventry, CV4, AL, UK. Electronic address: N.E.Dale@warwick.ac.uk.

Jack Butler (J)

School of Life Sciences, University of Warwick, Coventry, CV4, AL, UK.

Valentin-Mihai Dospinescu (VM)

School of Life Sciences, University of Warwick, Coventry, CV4, AL, UK.

Sarbjit Nijjar (S)

School of Life Sciences, University of Warwick, Coventry, CV4, AL, UK.

Articles similaires

Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin

Classifications MeSH